Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplantation
NCT01403389Phase 2Terminated
- Start
- Dec 2011
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of eculizumab in delayed graft function (DGF). Started Dec 2011; status: terminated.
02
Drugs
eculizumab
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT01403389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403389.